Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study.

@article{Aung2000ComparisonOT,
  title={Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study.},
  author={Tin Aung and Hon Tym Wong and Chan Chung Yip and Joy Yoke Ngan Leong and Yiong Huak Chan and Paul T K Chew},
  journal={Ophthalmology},
  year={2000},
  volume={107 6},
  pages={
          1178-83
        }
}
OBJECTIVE To compare the intraocular pressure (IOP)-reducing effect and side effects of 0.005% latanoprost once daily to 0.5% timolol twice daily in patients with primary chronic angle closure glaucoma (CACG). DESIGN Randomized, double-masked two-center clinical trial. PARTICIPANTS Thirty-two Asian patients with CACG, defined as glaucomatous optic neuropathy with a compatible visual field defect and at least 6 clock hours of synechial angle closure on gonioscopy were recruited. All patients… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

Long-term Therapeutic Outcome of Acute Primary Angle Closure in Japanese

  • Japanese Journal of Ophthalmology
  • 2007
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Primary angle closure glaucoma: What we know and what we don’t know

  • Progress in Retinal and Eye Research
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

Efficacy of latanoprost in management of chronic angle closure glaucoma.

  • Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH
  • 2009
VIEW 1 EXCERPT
CITES BACKGROUND

Efficacy of latanoprost in management of chronic angle closure glaucoma.

  • Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH
  • 2009
VIEW 1 EXCERPT
CITES BACKGROUND

Mean target intraocular pressure and progression rates in chronic angle-closure glaucoma.

  • Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
  • 2009

Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action.

  • Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
  • 2008